Your browser doesn't support javascript.
loading
A phase II trial of small-dose bortezomib, lenalidomide and dexamethasone (sVRD) as consolidation/maintenance therapy in patients with multiple myeloma.
Ibata, Soushi; Sato, Tsutomu; Kuroda, Hiroyuki; Nagamachi, Yasuhiro; Iyama, Satoshi; Fujimi, Akihito; Kamihara, Yusuke; Konuma, Yuichi; Yoshida, Masahiro; Tatekoshi, Ayumi; Hashimoto, Akari; Horiguchi, Hiroto; Ono, Kaoru; Murase, Kazuyuki; Takada, Kohichi; Miyanishi, Koji; Kobune, Masayoshi; Hirayama, Yasuo; Kato, Junji.
Afiliação
  • Ibata S; Department of Medical Oncology and Hematology, Sapporo Medical University School of Medicine, South-1 West-16, Chuo-ku, Sapporo, Japan.
  • Sato T; Department of Medical Oncology and Hematology, Sapporo Medical University School of Medicine, South-1 West-16, Chuo-ku, Sapporo, Japan. tsutomus@sapmed.ac.jp.
  • Kuroda H; Gastroenterology and Hematology/Clinical Oncology, Internal Medicine, Steel Memorial Muroran Hospital, Muroran, Japan.
  • Nagamachi Y; Department of Hematology, Kiyota Hospital, Sapporo, Japan.
  • Iyama S; Department of Medical Oncology and Hematology, Sapporo Medical University School of Medicine, South-1 West-16, Chuo-ku, Sapporo, Japan.
  • Fujimi A; Department of Hematology and Oncology, Oji General Hospital, Tomakomai, Japan.
  • Kamihara Y; Department of Medical Oncology and Hematology, Sapporo Medical University School of Medicine, South-1 West-16, Chuo-ku, Sapporo, Japan.
  • Konuma Y; Department of Hematology and Oncology, Asahikawa Red Cross Hospital, Asahikawa, Japan.
  • Yoshida M; Department of Medical Oncology and Hematology, Sapporo Medical University School of Medicine, South-1 West-16, Chuo-ku, Sapporo, Japan.
  • Tatekoshi A; Department of Medical Oncology and Hematology, Sapporo Medical University School of Medicine, South-1 West-16, Chuo-ku, Sapporo, Japan.
  • Hashimoto A; Department of Medical Oncology and Hematology, Sapporo Medical University School of Medicine, South-1 West-16, Chuo-ku, Sapporo, Japan.
  • Horiguchi H; Department of Medical Oncology and Hematology, Sapporo Medical University School of Medicine, South-1 West-16, Chuo-ku, Sapporo, Japan.
  • Ono K; Department of Medical Oncology and Hematology, Sapporo Medical University School of Medicine, South-1 West-16, Chuo-ku, Sapporo, Japan.
  • Murase K; Department of Medical Oncology and Hematology, Sapporo Medical University School of Medicine, South-1 West-16, Chuo-ku, Sapporo, Japan.
  • Takada K; Department of Medical Oncology and Hematology, Sapporo Medical University School of Medicine, South-1 West-16, Chuo-ku, Sapporo, Japan.
  • Miyanishi K; Department of Medical Oncology and Hematology, Sapporo Medical University School of Medicine, South-1 West-16, Chuo-ku, Sapporo, Japan.
  • Kobune M; Department of Medical Oncology and Hematology, Sapporo Medical University School of Medicine, South-1 West-16, Chuo-ku, Sapporo, Japan.
  • Hirayama Y; Division of Internal Medicine, Higashi Sapporo Hospital, Sapporo, Japan.
  • Kato J; Department of Medical Oncology and Hematology, Sapporo Medical University School of Medicine, South-1 West-16, Chuo-ku, Sapporo, Japan.
Cancer Chemother Pharmacol ; 78(5): 1041-1049, 2016 Nov.
Article em En | MEDLINE | ID: mdl-27738809
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Mieloma Múltiplo Tipo de estudo: Clinical_trials Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Chemother Pharmacol Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Japão
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Mieloma Múltiplo Tipo de estudo: Clinical_trials Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Chemother Pharmacol Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Japão